Tryptamine Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 25, 2025	Jun '24 Jun 30, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020
Market Capitalization	43	31	-	-	-	-
Enterprise Value	40	36	-	-	-	-
Last Close Price	0.03	0.02	-	-	-	-
PS Ratio	32.52	23.16	-	-	-	-
PB Ratio	7.68	5.47	-	-	-	-
P/TBV Ratio	8.22	5.85	-	-	-	-
EV/Sales Ratio	30.40	27.33	-	-	-	-
Debt / Equity Ratio	0.04	0.04	-0.56	-	-	0.00
Quick Ratio	3.69	3.69	0.23	1.52	19.72	5.29
Current Ratio	3.87	3.87	0.24	1.82	22.03	5.44
Return on Equity (ROE)	-	-	-	-295.89%	-286.37%	-
Return on Assets (ROA)	-	-	-185.67%	-142.79%	-148.30%	-
Return on Capital (ROIC)	-	-	-	-181.70%	-157.90%	-
Earnings Yield	-17.08%	-23.98%	-	-	-	-
Buyback Yield / Dilution	-460.94%	-45.33%	-346.62%	-51.73%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.